Portfolio - NeOnc Technologies Holdings, Inc.

NeOnc Technologies Holdings, Inc.

About
Science & Technology
Products
Media
Clinical Trials
Contact

HomePortfolio

Portfolio

16 October 2024, NEO212

NEO212 Tumor Trial
NEO100

Pediatric High-Grade-Glioma Study
12 February 2021, NEO100

NEO100-01 GBM TRIAL

account

cart

Stay on top of NeOnc's groundbreaking research, clinical trials, and our mission to revolutionize CNS therapeutics.

SUBSCRIBE TO ALERTS

Our innovative formulations offer pharmaceutical companies a new pathway to deliver potentially more effective treatments for CNS diseases, expanding possibilities for patients.

Facebook-f X-twitter Linkedin-in Instagram

Company

About
Science & Technology
Products
Media
Clinical Trials
Contact
Investors

Quick Links

Privacy Policy
Accessibility Statement
Terms Of Use
Sitemap

Contact

23975 Park Sorrento Suite 205 Calabasas, CA 91302

Need help? Call us

+1 (818) 570-NTHI

© Copyright NeOnc • All rights reserved • Website by

Sign in Create an Account

Username or email *

Password *

Lost your password?

Main menu

About
Science & Technology
Products
Media
Clinical Trials
Contact

Search for:

All category
Business
Digital Marketing
Introduction
New Services
Tips & Tricks
Uncategorized

Top